journal article·2007-09

In vitro effect of oligo-hydroxyalkanoates on the growth of mouse fibroblast cell line L929

Jie Sun, Zhongwei Dai, Yan Zhao, Guo-Qiang Chen

Biomaterials· Volume 28· Issue 27
Publisher page

Abstract

The cellular responses to polyhydroxyalkanoates (PHA) degradation products oligo-hydroxyalkanoates (OHAs) are very important factors that control the biocompatibility of these polymers when they are used in tissue-engineering applications. In this study, oligo(3-hydroxybutyrate) (OHB, Mn 2000), oligo(3-hydroxybutyrate-co-4-hydroxybutyrate) (O3HB4HB, Mn 2100, 6 mol% 4HB), oligo(3-hydroxybutyrate-co-3-hydroxyhexanoate) (OHBHHx, Mn 2800, 12 mol% 3HHx) and medium-chain-length oligo(3-hydroxyalkanoates) (OmclHAs, Mn 2300, 2 mol% 3-hydroxyhexanoate (3HHx), 25 mol% 3-hydroxyoctanoate, 71 mol% 3-hydroxydecanoate and 3 mol% 3-hydroxydodecanoate) were prepared as insoluble particles in aqueous solution. Liposomes were employed to encapsulate OHAs and facilitate their transfer into the cytosol. The methylthiazol tetrazolium (MTT) assay, a cell apoptosis study and the flow cytometry were used to evaluate cell viability of mouse fibroblast L929. OHAs in concentration lower than 20mg/l did not significantly affect cell viability, while OHAs over 40 mg/l reduced cell viability with more cell apoptosis, more cell death, delayed cell cycle and reduced cell proliferation. The cytotoxicity of OHAs decreased with increasing OHAs side chain length. It is proposed that medium-chain-length OHAs containing PHA, such as poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) and medium-chain-length PHA Poly(3-hydroxyalkanoates) (mcl PHA), are preferred for development and application as PHA-based tissue-engineering biomaterials.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: biodegradable polymer synthesis and properties · Microplastics and Plastic Pollution · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Doi · 2002
2. PHA applications: addressing the price performance issue I. Tissue engineering10.1016/S0141-8130(99)00022-7 ↗
3. Recent advances in microbial polyhydroxyalkanoates10.1016/j.procbio.2004.01.053 ↗
4. Perspective for the biotechnological production and utilization of biopolymers: metabolic engineering of polyhydroxyalkanoate biosynthesis pathways as successful example10.1002/1616-5195(200101)1:1<1::AID-MABI1>3.0.CO;2-B ↗
5. The application of polyhydroxyalkanoates as tissue engineering materials10.1016/j.biomaterials.2005.04.036 ↗
6. Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications10.1021/bm060317c ↗
7. Effects of crystallization of polyhydroxyalkanoate blend on surface physicochemical properties and resulting biocompatibility for chondrocytes10.1016/j.biomaterials.2004.09.041 ↗
8. Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility10.1016/S0142-9612(02)00426-X ↗
9. Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates10.1016/S0142-9612(01)00260-5 ↗
10. Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility10.1016/S0142-9612(02)00426-X ↗
11. Influence of dl-β-hydroxybutyric acid on cell proliferation and calcium influx10.1021/bm049465y ↗
12. The effect of d,l-β-hydroxybutyric acid on cell death and proliferation in L929 cells10.1016/j.biomaterials.2006.02.046 ↗
13. Martin DP, Peoples OP, Williams SE, Zhong LH. Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers, US Patent Appl 359086, 1999.
14. DL-3-hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts10.1152/ajpheart.00250.2002 ↗
15. () d-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease10.1172/JCI200318797 ↗
16. d-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease10.1073/pnas.97.10.5440 ↗
17. Transmembrane ion transport by polyphosphate/poly-(R)-3-hydroxybutyrate complexes
18. Low molecular weight complexed poly (3-hydroxybutyrate): a dynamic and versatile molecule in vivo10.1139/m95-167 ↗
19. d-(-)-Poly-β-hydroxybutyrate in membranes of genetically competent bacteria10.1128/jb.156.2.778-788.1983 ↗
20. Detection, synthesis, structure, and function of oligo (3-hydroxyalkanoates): contributions by synthetic organic chemists10.1016/S0141-8130(99)00037-9 ↗
21. Hyperproduction of polyesters consisting of medium-chain-length hydroxyalkanoate monomers by strain Pseudomonas stutzeri 131710.1023/A:1002714102347 ↗
22. Biodegradation of aliphatic polyesters
23. Gas chromatographic, liquid chromatorgraphic and gas chromatographic-mass spectrometric identification of degradation products in accelerated aged microbial polyhydroxyalkanoates10.1016/0021-9673(94)80341-2 ↗
24. Oligoesters of (R)-3-hydroxybutanoic acid: transmembrane transport of Ca2+ across vesicle bilayers10.1021/ma981256g ↗
25. Effect of composition of poly (3-hydroxybutyrate-co-3-hydroxylhexanoate) on growth of fibroblast and osteoblast10.1016/j.biomaterials.2004.03.023 ↗
26. Study on the three-dimensional proliferation of rabbit articular cartilage derived chondrocytes on polyhydroxyalkanoate scaffolds10.1016/S0142-9612(02)00136-9 ↗
27. Inhibitive effects of glucose and free fatty acids on proliferation of human vascular endothelial cells in vitro
28. On the biodegradation of poly-beta-hydroxybutyrate homopolymer and poly beta-hydroxybutyrate-hydroxyvalerate copolymers10.1016/0142-9612(87)90102-5 ↗
29. Increased hydrophilicity of microbial polyhydroxyalkanoates via hyaluronan coating reduced growth of mouse fibroblast L929 cells10.1016/S0142-9612(03)00356-9 ↗
30. Poly(hydroxybutyrate-co-hydroxyhexanoate) promoted production of extracellular matrix of articular cartilage chondrocytes in vitro10.1016/S0142-9612(03)00367-3 ↗
31. Antibiotic release from biodegradable PHBV microparticles10.1016/S0168-3659(98)00195-3 ↗
32. The dimer and trimer of 3-hydroxybutyrate oligomer as a precursor of ketone bodies for nutritional care10.1177/0148607199023006321 ↗
33. Cell response of cultured macrophages, fibroblasts, and co-cultures of Kupffer cells and hepatocytes to particles of short-chain poly [(R)-3-hydroxybutyric acid]10.1007/BF00121191 ↗
34. Characterization of the cell response of cultured macrophages and fibroblasts to particles of short-chain poly [(R)-3-hydroxybutyric acid]10.1002/(SICI)1097-4636(199604)30:4<429::AID-JBM1>3.0.CO;2-R ↗
35. Non-storage poly-(R)-3-hydroxyalkanoates (complexed PHA) in prokaryotes and eukaryotes
36. Mechanisms and kinetics of liposome–cell interactions10.1016/S0169-409X(99)00037-X ↗
37. A fluorescence assay to monitor vesicle fusion and lysis10.1016/S0021-9258(19)45313-1 ↗
38. Development of non-viral vectors for systemic gene delivery10.1016/S0168-3659(01)00494-1 ↗
39. The mechanical properties of a thermoplastic elastomer produced by the bacterium Pseudomonas oleovorans10.5254/1.3538640 ↗
40. Checkpoint: controls that ensure the order of cell cycle events10.1126/science.2683079 ↗
41. Some properties of poly (3-hycroxubutyrate) and poly (3-hydroxyvalerate) blends10.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-0 ↗
42. Biodegradable biomedical polymers: a review of degradation of and in vivo response to polylactides and polyhydroxyalkanoates
43. Degradation of microbial polyesters10.1023/B:BILE.0000036599.15302.e5 ↗